Trial Profile
Effect of pegfilgrastim when administered on the same day after chemotherapy in US patients with solid tumours and non-Hodgkin's lymphoma
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 07 Jul 2015
Price :
$35
*
At a glance
- Drugs Pegfilgrastim (Primary)
- Indications Febrile neutropenia
- Focus Therapeutic Use
- 02 Jun 2015 Results presented at the 51st Annual Meeting of the American Society of Clinical Oncology.
- 03 May 2015 New trial record